PER3 Pro415Ala — The Ultra-Early-Riser Variant
The PER3 gene | Period Circadian Regulator 3, one of three Period proteins that
form the negative feedback arm of the molecular circadian clock
is a master timekeeper in every cell of your body. Its protein accumulates during
the day, enters the nucleus, and shuts down the very transcription machinery that
made it — completing one oscillation roughly every 24 hours. The rs150812083
variant swaps a proline for an alanine at position 415, and the consequences reach
all the way from molecular clock mechanics to sleep timing, seasonal mood, and
family history of early-rising disorder.
This variant is rare — found in roughly 1 in 200 people of European descent —
but its effect is dramatic. It was first identified as the cause of
familial advanced sleep phase syndrome 3 (FASPS3) | An autosomal dominant
circadian rhythm disorder in which affected individuals fall asleep and wake
approximately 4 hours earlier than average, with sleep onset around 6-8 PM
and spontaneous waking around 4 AM, and later
confirmed as a strong morningness signal in the largest chronotype GWAS to date.
The Mechanism
At position 415, proline is a structurally rigid amino acid that imposes a sharp
bend in the local protein chain. The G allele substitutes the flexible alanine,
disrupting a conserved region near the CRY-binding interface | CRY1/CRY2 proteins
partner with PER proteins to form the transcriptional repressor complex that
feeds back to inhibit CLOCK-BMAL1 activity.
The functional consequence, shown in Zhang et al. 2016 |
Zhang L et al. A PERIOD3 variant causes a circadian phenotype and is associated
with a seasonal mood trait. PNAS, 2016.,
is counterintuitive: the Pro415Ala protein is less stable than wild-type —
it degrades faster, accumulates to lower nuclear levels despite higher mRNA
production, and loses repressor efficiency. Without sufficient PER3 to dampen
the CLOCK-BMAL1 feedback loop, the clock cycles more rapidly — shortening
the intrinsic circadian period and advancing the entire sleep-wake cycle.
The same variant also impairs PER3's ability to stabilize PER1 and PER2
proteins, compounding the clock acceleration. Transgenic mice expressing the
human P415A/H417R allele showed an altered circadian period under constant
light conditions and, strikingly, showed phase-shifted activity and
depression-like behavior in short photoperiod conditions mimicking winter —
directly linking this circadian variant to seasonal affective disorder (SAD).
The Evidence
The variant was first described in a three-generation family with FASPS3 by
Zhang et al. (PNAS, 2016) | Zhang L et al. A PERIOD3 variant causes a
circadian phenotype and is associated with a seasonal mood trait.
PNAS 113(11):E1536-44..
Affected members fell asleep by midnight and woke spontaneously by 8:15 AM
(advanced by ~4 hours relative to population average), and scored at the
99th percentile for seasonal mood variation — with worst symptoms in
December and January. The variant co-occurs on the same chromosome copy
as a second change (rs139315125, H417R); in vitro studies showed both
positions contribute to protein destabilization.
At the population scale, Jones et al. (Nature Communications, 2019) |
Jones SE et al. Genome-wide association analyses of chronotype in 697,828
individuals provides insights into circadian rhythms. Nat Commun 10:343.
found the G allele associated with self-reported morningness at extraordinary
significance (OR=1.44, P=2×10⁻³⁸) in a meta-analysis of UK Biobank and
23andMe participants — making it one of the strongest single-variant effects
on chronotype ever identified. Notably, the objective effect on sleep timing
was modest (~8 minutes earlier by actigraphy), suggesting the variant's
primary impact on subjective sleep experience is disproportionate to its
absolute phase advance.
Practical Implications
Carriers of the G allele experience a genuine biological drive toward
earlier sleep timing. Unlike lifestyle-driven early rising, this variant
reflects an intrinsically faster molecular clock. The clinical consequence
depends on whether your environment accommodates your advanced phase:
Early timing aligns well with standard work and school schedules, but
creates problems in social contexts demanding late-night participation.
The more serious concern is the seasonal mood dimension. Because PER3
governs how the circadian clock adapts to photoperiod (day length), a
destabilized PER3 may impair seasonal adaptation — the same mechanism
that causes winter-pattern SAD. G allele carriers in the FASPS3 family
showed seasonality scores above the 97th percentile, with winter depression.
Evening bright light therapy is the most evidence-supported intervention
for FASPS: light between 7 and 9 PM shifts the phase-delaying window
of the circadian phase response curve | The PRC describes how light
exposure at different clock times shifts the circadian phase; light in
the evening hours (the delay zone) pushes the clock later,
counteracting the pathological advance. Morning bright light avoidance
(or blue-light filtering) prevents further clock advancement on waking.
Interactions
This variant is reported on the same haplotype as rs139315125 (H417R
in PER3), seven base pairs downstream. The two changes consistently
co-occur in published FASPS3 families and functional studies always test
them together. Either variant alone may have attenuated effects; the
compound haplotype is the clinically relevant combination.
PER3 Pro415Ala sits in the same feedback loop as rs228697 (PER3
Pro864Ala) and rs35333999 (PER2 V903I). Those variants lengthen
circadian period (evening-shifting), while rs150812083 shortens it
(morning-shifting). An individual carrying both an evening-shifting PER2
variant and this advanced-phase PER3 variant would experience opposing
forces, potentially producing an unstable or irregular circadian rhythm
rather than a clean chronotype in either direction.
The seasonal mood dimension suggests potential interaction with melatonin
pathway variants such as rs10830963 (MTNR1B) and serotonin transporter
variants; no published studies have formally characterized these
gene-gene interactions.
All Genotypes
Normal PER3 stability — no advanced sleep phase tendency from this variant
You have two copies of the common C allele, producing proline at position 415 of the PER3 protein. Your PER3 protein has normal stability and repressor function, and your circadian clock is not accelerated by this variant. This is the most common genotype — approximately 99% of people carry it. Your sleep timing and seasonal mood regulation are not affected by this particular PER3 variant. Other genetic and lifestyle factors determine your individual chronotype.
One copy of the Pro415Ala variant — biologically earlier sleep timing and possible seasonal mood sensitivity
You carry one copy of the G allele, producing the less-stable alanine variant of PER3 in half your cells. This single copy is sufficient to accelerate circadian period and shift sleep timing earlier — FASPS3 is autosomal dominant, meaning one copy causes the phenotype. Approximately 1% of people of European ancestry carry this genotype. It is exceptionally rare in East Asian and African populations. In the Jones et al. 2019 GWAS of 697,828 individuals, the G allele conferred an odds ratio of 1.44 for self-reported morningness (P=2×10⁻³⁸). Affected family members in the Zhang et al. 2016 study went to sleep around midnight and woke by 8:15 AM, with seasonality scores above the 97th–99th percentile for winter-pattern mood variation.
Two copies of the Pro415Ala variant — extremely rare, profound clock acceleration expected
You carry two copies of the G allele. This is an exceptionally rare genotype — the G allele frequency is approximately 0.5% globally, making GG homozygosity expected in roughly 1 in 40,000 people. No published studies have specifically described GG homozygotes; all clinical characterization of FASPS3 is from heterozygous carriers. Given the autosomal dominant nature of this variant and the dose-dependent destabilization of PER3 protein, GG homozygotes would be expected to have more severe circadian period shortening than heterozygotes — potentially pushing sleep onset and wake times even earlier than typical FASPS3 carriers, and with greater seasonal mood vulnerability.